SUMMARY

• Please refer to product labeling for storage and stability information.
• Johnson & Johnson cannot recommend any practices, procedures, or storage conditions that deviate from product labeling and are not approved by the regulatory agencies.
• The density of amivantamab (drug product, 350 mg/7 mL [50 mg/mL]) is
  1.044 g/mL (at ambient room temperature).¹
• The specific gravity of amivantamab (drug product, 350 mg/7 mL [50 mg/mL]) is 1.044.²

Literature Search

A literature search of MEDLINE^®, Embase^®, BIOSIS Previews^®, and Derwent Drug File (and/or other resources, including internal/external databases) was conducted on 07 April 2025.